Long-Term Neuropsychiatric Consequences of "Ecstasy" (MDMA): A Review
Alonso Montoya, Renée Sorrentino, Scott E. Lukas, Bruce H. Price
Harvard Review of Psychiatry January 1, 2002 DOI: 10.1080/hrp.10.4.212.220 via OpenAlex
Summary
AI-generated from the abstractRepeated use of the recreational drug ecstasy (MDMA) is linked to sleep, mood, and anxiety disturbances, elevated impulsiveness, memory deficits, and attention problems that may persist for up to 2 years after stopping. Experimental studies in animals and humans indicate that MDMA damages serotonergic neurons. In a subset of humans, particularly adolescents, serotonin depletion from MDMA use may hasten or enhance vulnerability to a range of neuropsychiatric problems. The reviewed studies provide substantial evidence that MDMA causes neuronal damage, but more research is needed to determine if this destruction can have long-term or permanent neuropsychiatric consequences.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Chronic recreational users of ecstasy (MDMA), including adolescents |
| Topics | Anxiety MDMA Serotonin |
| Keywords | Psychology Hallucinogen |
| Citations | 102 |
| Key finding | Repeated ecstasy use is associated with persistent sleep, mood, anxiety, memory, and attention problems, and evidence indicates MDMA causes serotonergic neuronal damage in animals and humans. |
Abstract
The recreational drug "ecstasy" (3,4-methylenedioxymethamphetamine, or MDMA) is widely used by young people throughout the world. Experimental studies indicate that MDMA damages serotonergic neurons in animals and possibly in humans. Repeated use may induce long-term neurotoxic effects, with cognitive and behavioral implications. We reviewed both the preclinical and the clinical literature to assess the evidence for persistent neuropsychiatric sequelae in humans. We focused on studies of chronic recreational use and reports of presence or absence of neurological, psychiatric, and psychological problems related to MDMA exposure. These investigations show repeated use of ecstasy to be associated with sleep, mood, and anxiety disturbances, elevated impulsiveness, memory deficits, and attention problems, which may persist for up to 2 years after cessation. In a subset of humans, particularly adolescents, depletion of serotonin by MDMA use may hasten or enhance vulnerability to a wide array of neuropsychiatric problems. Together, the studies reviewed provide substantial evidence that MDMA causes neuronal damage in animals and humans. Additional research is necessary to determine whether the MDMA-induced destruction of serotonergic neurons can have long-term and possibly permanent neuropsychiatric consequences in humans.